Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China.

Fu, Zhong-Chao; Cheng, Xiao-Gui; Zhang, Guo-Wen; Shi, Ran-Geng; Zhang, Li-Jun; Sun, Hai-Tian; Huang, Jin-Xian

Fu, Zhong-Chao; Cheng, Xiao-Gui; Zhang, Guo-Wen; Shi, Ran-Geng; Zhang, Li-Jun; Sun, Hai-Tian; Huang, Jin-Xian.

Affiliation

Fu ZC; Division of Rheumatology, Department of Medicine, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Cheng XG; Department of Pharmacy, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Zhang GW; Department of Pathological Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.
Shi RG; Division of Rheumatology, Department of Medicine, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Zhang LJ; Department of Pathological Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.
Sun HT; Special Inspection Project Department, Guangzhou Huayin Medical Examination Center, Guangzhou, Guangdong, China.
Huang JX; Division of Rheumatology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.

Int J Rheum Dis ; 27(5): e15190, 2024 May.

Article in En | MEDLINE | ID: mdl-38736279

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals / Adalimumab / Axial Spondyloarthritis Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Rheum Dis Journal subject: REUMATOLOGIA Year: 2024 Document type: Article Affiliation country: China Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google